Eurogentec enters in the Therapeutic Oligonucleotides Manufacturing Field

Products & Services

Combining over 30 years of expertise in oligonucleotide synthesis to 20 years of biopharmaceutical GMP manufacturing, we now offer GMP therapeutic oligonucleotides manufacturing for early clinical phases.

GMP certification by the Belgium Authorities for the manufacturing and quality control of therapeutic oligonucleotides according to ICH Q7 is planned for Q1 2019.

 

 

Attached Files

Trending Now

Products & Services

Pichia pastoris: benefits and challenges in r...

Products & Services

Evolution of Multiplex PCR: Benefits, Challenge...

Kaneka Eurogentec completes commercial mRNA GMP facility expansion

Previous post

Kaneka Eurogentec receives GMP accreditation for its new state-of-the-art facility in time for the production of DNA vaccines against COVID-19

Next post

Recommended for you

Kaneka Eurogentec completes commercial mRNA..

Company

Newly accredited GMP facility for commercial manufacturing of mRNA in anticipation of customer BLA submission....
Continue Reading
24-25 March 2026

Nextgen Biomed

London, UK

Meet Eurogentec at "Nextgen Biomed"

@ London, UK
📅March 24-25, 2026
📍London (UK) - Booth #61
...
Continue Reading
17-20 November 2025

Medica

Düsseldorf, DE

Meet our team at "Medica"

@ Düsseldorf, DE
📅 November 17-20, 2025
📍Dusseldorf (DE) - AWEX Belgian Pavilion (Hall 15)
...
Continue Reading